Here are relevant reports on : workflow-orchestration-market

• Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2030

  The next-generation sequencing market, valued at USD 13.95 billion in 2024, stood at USD 14.94 billion in 2025 and is projected to advance at a resilient CAGR of 14.6% from 2025 to 2030, culminating in a forecasted valuation of USD 29.53 billion by the end of the period. The next-generation sequencing (NGS) market continues to grow steadily. A key driver of this expansion is the clinical adoption of NGS across oncology, rare diseases, reproductive health, and infectious diseases. This trend is also accompanied by lower cost per genome and the launch of higher-throughput benchtop and clinical instruments.

  • Published: March 2026
  • Price: $ 4950
  • TOC Available:

• Biobanking Market by Product (Equipment, Consumables, Software), Services (Virtual), Operation (Automated), Workflow (Storage, Collection, Transport), Sample (Blood, Cell Lines, Nucleic Acids), Application, Ownership, End User - Global Forecast to 2030

  The global biobanking market, valued at US$7.16 billion in 2024, stood at US$7.65 billion in 2025 and is projected to advance at a resilient CAGR of 9.1% from 2025 to 2030, culminating in a forecasted valuation of US$11.82 billion by the end of the period. Several factors contribute to the growth of the biobanking market, including growing focus on precision or personalized medicine, continuously expanding cell & gene therapy pipeline, and end-to-end automation for sample handling & storage.

  • Published: July 2025
  • Price: $ 4950
  • TOC Available:

• Healthcare Information Exchange Market Size, Share & Trends by Type (Direct, Query, Consumer), Implementation (Hybrid, Centralised, Federated), Setup (Private, Public), Solution (Portal, Platform), Application (Workflow, Messaging), End User, & Region - Global Forecast to 2029

  The global healthcare information exchange market, valued at US$1.5 billion in 2023, stood at US$1.7 billion in 2024 and is projected to advance at a resilient CAGR of 10.2% from 2024 to 2029, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The growth of the market is mainly driven by an increasing focus on population health management, value-based care models, and regulatory mandates for electronic health records (EHRs). Moreover, the increasing digitization of healthcare systems worldwide and the growing emphasis on interoperability and care coordination within the healthcare industry have propelled the adoption of HIE solutions.

  • Published: July 2024
  • Price: $ 4950
  • TOC Available:

• Germany Next Generation Sequencing Market by Product (Reagents, Kits, Platforms) Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application - Forecast to 2031

  The Germany Next Generation Sequencing market, valued at USD 0.85 billion in 2025, stood at USD 0.93 billion in 2026 and is projected to advance at a resilient CAGR of 16.0% from 2026 to 2031, culminating in a forecasted valuation of USD 1.96 billion by the end of the period. Next-generation sequencing refers to high-throughput DNA sequencing technologies that are not based on Sanger sequencing.

  • Published: March 2026
  • Price: $ 4950
  • TOC Available:

• Single-use Bioprocessing Market by Product (Equipment [Bioreactors, Filtration, Chromatography], Consumables [Filters, Bags, Assemblies, Sensors]), Application (Storage, Mixing), Workflow (Upstream), Molecule Type (mAbs, Vaccines) - Global Forecast to 2030

  The global single-use bioprocessing market, valued at US$16.51 billion in 2024, stood at US$18.01 billion in 2025 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2030, culminating in a forecasted valuation of US$33.67 billion by the end of the period. The single-use bioprocessing market is witnessing significant expansion due to the increasing adoption of disposable technologies in the biopharmaceutical sector.

  • Published: October 2025
  • Price: $ 7150
  • TOC Available:

• AI for Customer Service Market by Product Type (AI Agents, Recommendation Systems (Knowledge Base Platforms), Workflow Automation (RPA, CRM Automation), Content Generation, Customer Journey Analytics, Service Quality Management) - Global Forecast to 2030

  The AI for customer service market is projected to reach USD 47.82 billion by 2030, at a CAGR of 25.8% during the forecast period. Some major players in the AI for customer service Market include Microsoft (US), IBM (US), Google (US), AWS (US), Salesforce (US), Atlassian (Australia), ServiceNow (US), SAP (Germany), Zendesk (US), Sprinklr (US), OpenAI (US), Aisera (US), UiPath (US), HubSpot (US), NICE (Israel), Intercom (US),Qualtrics (US), Freshworks (US), LivePerson (US), HelpShift (US), Yellow.ai (US), Cogito (US), SmartAction (US), Talkdesk (US), Five9 (US), RingCentral (US), Nextiva (US), Kore.ai (US), Dynamic Yield (US), Jio Haptik (India), Oracle (US), Afiniti (Bermuda), Kommunicate (US), Help Scout (US), Gorgias (US), Atera (Israel), Ada (US), Kustomer (US), Levity (Germany), Cognigy (Germany), Engageware (US), Netomi (US), Level AI (US), Sybill AI (US), OneAI (US), Brainfish (Australia), SentiSum (England), Balto (US), Tovie AI (UK), Guru (US), Tidio (US), Quiq (US), Aircall (US), OneReach.ai (US), Cresta (US), Deepdesk (Netherlands), Front (US), Fullview (Denmark), Crescendo AI (US), Gridspace (US).

  • Published: February 2025
  • Price: $ 4950
  • TOC Available:

• Single Cell Sequencing Market by Product (Reagents & Kits, Platforms, Software), Workflow (Presequencing), Service (Sample Preparation, Bioinformatics), Sequencing (scRNA, scDNA), Application (Research, Diagnostic), End User - Global Forecast to 2030

  The global Single Cell Sequencing market, valued at US$1.89 billion in 2024, stood at US$1.95 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$3.46 billion by the end of the period. This growth is driven by advancements in single-cell workflow, including more efficient cell isolation methods, improved library preparation kits, and high-throughput, cost-effective sequencing platforms.

  • Published: July 2025
  • Price: $ 4950
  • TOC Available:

• Ligase Enzymes Market by Type (DNA, RNA), Source (Viral, Bacterial, Eukaryotic), Grade (RUO, GMP, Diagnostic), Molecular Biology Workflow (Cloning, Sequencing, Synthetic Biology), Application (Research, Diagnostic, Therapeutic) - Global Forecast 2030

  The global ligase enzymes market, valued at US$0.25 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$0.36 billion by the end of the period. The ligase enzymes market is growing due to the rising demand for molecular diagnostics, the increasing adoption of next-generation sequencing (NGS), expanding applications in synthetic biology, and continuous advancements in enzyme engineering.

  • Published: September 2025
  • Price: $ 4950
  • TOC Available:

• UK Next-generation Sequencing Market by Product (Reagents, Kits, Platforms), Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application, Competition - Forecast to 2031

  The UK next-generation sequencing market is projected to grow from USD 795.8 million in 2026 to USD 1,587.2 million by 2031, at a CAGR of 14.8% during the forecast period. The report profiles key players such as Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Oxford Nanopore Technologies plc. (UK), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (US), and Eurofins Scientific (Luxembourg).

  • Published: April 2026
  • Price: $ 4950
  • TOC Available:

• Nuclear Medicine Software Market by Software (Image Management, Workflow, PACS, Dosimetry, Treatment, AI/Analytics), Application (Diagnosis, Treatment, Theranostics, Research), Disease (Onco, Neuro, Cardio), End User & Region - Global Forecast to 2030

  The global nuclear medicine software market, valued at US$887.5million in 2024, stood at US$970.0 million in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of US$1,491.5 million by the end of the period. This growth is mainly driven by the increasing demand for early and accurate diagnostics, as precision imaging is essential for treatment planning.

  • Published: July 2025
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50